Rituximab can be useful as treatment for minimal residual disease in bcr-abl-positive acute lymphoblastic leukemia (Q73699658)
scientific article published on 01 January 2001
Language:
Current Data About Rituximab can be useful as treatment for minimal residual disease in bcr-abl-positive acute lymphoblastic leukemia
(P31) (Q13442814)
(P248)
(P698) 11281397
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11281397%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, November 6, 2019

(P50) (Q50238034)
(P1545) 2
(P248)
(P698) 11281397
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11281397%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, November 6, 2019

(P304) 225-227
(P248)
(P698) 11281397
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11281397%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, November 6, 2019

(P433) 2
(P248)
(P698) 11281397
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11281397%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, November 6, 2019

(P478) 27
(P248)
(P698) 11281397
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11281397%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, November 6, 2019

(P577) Monday, January 1, 2001
(P248)
(P698) 11281397
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11281397%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, November 6, 2019

(P921) (Q18553852)
(P887)

(Q412323)
(P887)

(P1433) (Q4941523)
(P248)
(P698) 11281397
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11281397%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, November 6, 2019

(P1476) "Rituximab can be useful as treatment for minimal residual disease in bcr-abl-positive acute lymphoblastic leukemia" (language: en)
(P248)
(P698) 11281397
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11281397%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, November 6, 2019

(P2093) Jándula BM
(P1545) 1
(P248)
(P698) 11281397
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11281397%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, November 6, 2019

Marín P
(P1545) 3
(P248)
(P698) 11281397
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11281397%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, November 6, 2019

Vivancos P
(P1545) 4
(P248)
(P698) 11281397
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11281397%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, November 6, 2019

(P2860) (Q73399826)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FSJ.BMT.1702706
(P813) Thursday, January 7, 2021
(P887)

other details
description scientific article published on 01 January 2001

External Links
(P356) 10.1038/SJ.BMT.1702706
(P698) 11281397
(P6179) 1040180548